Cite
Reynolds EC, O'Brien-Simpson N, Rowe T, et al. Prospects for treatment of Porphyromonas gingivalis-mediated disease - immune-based therapy. J Oral Microbiol. 2015;7:29125doi: 10.3402/jom.v7.29125.
Reynolds, E. C., O'Brien-Simpson, N., Rowe, T., Nash, A., McCluskey, J., Vingadassalom, D., & Kleanthous, H. (2015). Prospects for treatment of Porphyromonas gingivalis-mediated disease - immune-based therapy. Journal of oral microbiology, 729125. https://doi.org/10.3402/jom.v7.29125
Reynolds, Eric C, et al. "Prospects for treatment of Porphyromonas gingivalis-mediated disease - immune-based therapy." Journal of oral microbiology vol. 7 (2015): 29125. doi: https://doi.org/10.3402/jom.v7.29125
Reynolds EC, O'Brien-Simpson N, Rowe T, Nash A, McCluskey J, Vingadassalom D, Kleanthous H. Prospects for treatment of Porphyromonas gingivalis-mediated disease - immune-based therapy. J Oral Microbiol. 2015 Sep 18;7:29125. doi: 10.3402/jom.v7.29125. eCollection 2015. PMID: 26387645; PMCID: PMC4576420.
Copy
Download .nbib